Tolerance and nasal histopathologic effects of long-term, low-dose intranasal recombinant interferon alpha-2A (Roferon-A)
- 1 October 1987
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 8 (3) , 139-149
- https://doi.org/10.1016/0166-3542(87)90067-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Human Nasal Mucosal Responses to Topically Applied Recombinant Leukocyte A InterferonThe Journal of Infectious Diseases, 1987
- Intranasal Interferon- 2b for Seasonal Prophylaxis of Respiratory InfectionThe Journal of Infectious Diseases, 1986
- Role of interferon in lymphocyte recruitment into the skinCellular Immunology, 1986
- Prevention of Natural Colds by Contact Prophylaxis with Intranasal Alpha2-InterferonNew England Journal of Medicine, 1986
- Prophylactic Efficacy of Intranasal Alpha2-Interferon against Rhinovirus Infections in the Family SettingNew England Journal of Medicine, 1986
- Tolerance of one‐month intranasal interferonJournal of Medical Virology, 1985
- Intranasal Interferon- 2 Prophylaxis of Natural Respiratory Virus InfectionThe Journal of Infectious Diseases, 1985
- Prophylactic efficacy and tolerance of low-dose intranasal interferon-alpha2 in natural respiratory viral infectionsAntiviral Research, 1985
- Intranasally Applied Recombinant Leukocyte A Interferon in Normal Volunteers. II. Determination of Minimal Effective and Tolerable DoseThe Journal of Infectious Diseases, 1984
- Effects of bacteria-produced human alpha, beta, and gamma interferons on in vitro immune functionsCellular Immunology, 1984